HPV+ Recurrent/Metastatic Head and Neck Cancer - Market Insight, Epidemiology and Market Forecast - 2030

  • RnM4231001
  • |
  • 20 October, 2020
  • |
  • 200 Pages
  • |
  • DelveInsight
  • |
  • Pharma & Healthcare

Make an enquiry before buying this Report



Purchase this Report

$6,950.00
$13,900.00
$20,850.00
5,525.25
11,050.50
16,575.75
6,428.75
12,857.50
19,286.25
1,087,119.00
2,174,238.00
3,261,357.00
580,533.50
1,161,067.00
1,741,600.50
Credit card Logo